What labs should be ordered for a patient with hypercalcemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Evaluation for Hypercalcemia

For patients with hypercalcemia, initial laboratory evaluation should include intact parathyroid hormone (iPTH), phosphorus, magnesium, renal function tests, 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels, and urinary calcium/creatinine ratio to differentiate PTH-dependent from PTH-independent causes. 1

Initial Laboratory Assessment

The following tests should be ordered when evaluating hypercalcemia:

  1. Calcium levels

    • Total serum calcium
    • Ionized calcium (if available)
    • Corrected calcium calculation: Corrected calcium = Total calcium + 0.8 × (4.0 - serum albumin) 1
  2. Parathyroid hormone assessment

    • Intact parathyroid hormone (iPTH) - most important initial test to distinguish PTH-dependent from PTH-independent causes 1, 2
  3. Other electrolytes and minerals

    • Phosphorus (typically low in hyperparathyroidism)
    • Magnesium
    • Serum electrolytes 1
  4. Renal function

    • Blood urea nitrogen (BUN)
    • Serum creatinine 1, 3
  5. Vitamin D status

    • 25-hydroxyvitamin D
    • 1,25-dihydroxyvitamin D (especially important for granulomatous disorders) 1
  6. Urinary studies

    • Urinary calcium/creatinine ratio (helps distinguish familial hypocalciuric hypercalcemia) 1

Additional Testing Based on Clinical Suspicion

After initial laboratory assessment, additional testing may be warranted based on clinical presentation and initial results:

  • If PTH is elevated or inappropriately normal with hypercalcemia:

    • Consider genetic testing for familial disorders (MEN syndromes, HPT-JT syndrome) 1
    • 24-hour urine calcium (to distinguish primary hyperparathyroidism from familial hypocalciuric hypercalcemia)
  • If PTH is suppressed:

    • Serum protein electrophoresis and free light chains (to evaluate for multiple myeloma) 2
    • Tumor markers appropriate for suspected malignancy
    • TSH (thyroid disorders can cause hypercalcemia) 1
    • Complete blood count (to evaluate for hematologic malignancies) 3
    • Liver function tests 3

Diagnostic Algorithm

  1. Measure PTH level with calcium:

    • High/normal PTH + high calcium = Primary hyperparathyroidism (most common in outpatient setting) 2, 4
    • Low PTH + high calcium = Non-PTH mediated hypercalcemia (malignancy, granulomatous disease, medications) 4
  2. For PTH-dependent hypercalcemia:

    • Check 24-hour urinary calcium
    • Low urinary calcium suggests familial hypocalciuric hypercalcemia
    • High urinary calcium suggests primary hyperparathyroidism 4
  3. For PTH-independent hypercalcemia:

    • Check 1,25-dihydroxyvitamin D levels (elevated in granulomatous disorders)
    • Check 25-hydroxyvitamin D levels (elevated in vitamin D toxicity)
    • Evaluate for malignancy (most common cause in hospitalized patients) 2, 4

Common Pitfalls to Avoid

  • Failing to correct calcium for albumin when ionized calcium is not available 1
  • Not measuring PTH as the first step in differentiating causes of hypercalcemia 1, 2
  • Overlooking medication causes of hypercalcemia (thiazide diuretics, lithium, calcium/vitamin D supplements) 5
  • Focusing only on laboratory values without addressing the underlying cause 1
  • Delaying treatment of severe hypercalcemia while completing diagnostic workup 1

When to Refer to a Specialist

Refer patients with hypercalcemia to an endocrinologist when:

  • Hyperparathyroidism is suspected
  • Complex electrolyte disturbances are present
  • Familial disorders are suspected (MEN syndromes, HPT-JT)
  • Patients have significant kidney injury (eGFR < 30 mL/min/1.73 m²) 1

By systematically approaching the laboratory evaluation of hypercalcemia with these tests, clinicians can efficiently determine the underlying cause and initiate appropriate management to reduce morbidity and mortality associated with this condition.

References

Guideline

Management of Hypercalcemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hypercalcemia: A Review.

JAMA, 2022

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Differential diagnosis of hypercalcemia.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1991

Research

Electrolytes: Calcium Disorders.

FP essentials, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.